title: The application of genetics and genomics to cancer prevention.
abstract: Advances in technology have accelerated the translation of genetics and genomics into the arena of cancer prevention. This provides unique opportunities to individualize cancer risk prediction so early intervention can either modify risk or allow for early diagnosis thereby potentially decreasing the morbidity and mortality of cancer and containing costs. While the full potential of these genetic/genomic discoveries have yet to be realized, many have clear clinical relevance such as the value of family history and/or tumor profiling to identify those who may harbor a mutation in a cancer susceptibility gene and are therefore candidates for genetic testing. Here, we provide an overview of the scope of genetic and genomic influences on cancer risk assessment and the entire spectrum of cancer prevention.
authors.affiliation: Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. calzonek@mail.nih.gov
authors.forename: Kathleen
authors.initials: K
authors.lastname: Calzone
authors.forename: Daniel
authors.initials: D
authors.lastname: Wattendorf
authors.forename: Barbara K
authors.initials: BK
authors.lastname: Dunn
mesh_terms: D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D006801:Humans; D009363:Neoplasm Proteins / Q000235:genetics*; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology / Q000517:prevention & control*; D010597:Pharmacogenetics
chemical_list: D016588:Anticarcinogenic Agents; D009363:Neoplasm Proteins
references.citation: Breast Cancer Res Treat. 2005 Jun;91(3):249-58
references.pmid: 15952058
references.citation: Nat Genet. 2006 Aug;38(8):873-5
references.pmid: 16832357
references.citation: Breast Cancer Res. 2005 Mar 29;7(6):E7
references.pmid: 16280043
references.citation: N Engl J Med. 2010 Mar 18;362(11):986-93
references.pmid: 20237344
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1083-8
references.pmid: 20332264
references.citation: J Clin Oncol. 2010 May 10;28(14):2423-9
references.pmid: 20385997
references.citation: Clin Pharmacol Ther. 2008 Feb;83(2):234-42
references.pmid: 17971818
references.citation: Ann Intern Med. 2009 Dec 15;151(12):872-7
references.pmid: 19884615
references.citation: Cancer Res. 2009 Mar 1;69(5):1722-7
references.pmid: 19244106
references.citation: J Med Genet. 2004 Feb;41(2):81-91
references.pmid: 14757853
references.citation: Nat Rev Cancer. 2009 Aug;9(8):576-86
references.pmid: 19629072
references.citation: Breast Cancer Res. 2007;9(1):R7
references.pmid: 17244352
references.citation: J Clin Oncol. 2005 Dec 20;23(36):9312-8
references.pmid: 16361630
references.citation: Nat Biotechnol. 2006 Sep;24(9):1083-90
references.pmid: 16964214
references.citation: J Clin Oncol. 2003 Feb 15;21(4):593-601
references.pmid: 12586794
references.citation: Ann Intern Med. 2007 Oct 2;147(7):515-7
references.pmid: 17909212
references.citation: J Clin Oncol. 2006 Aug 1;24(22):3708-9; author reply 3709
references.pmid: 16877740
references.citation: Cancer Causes Control. 2007 Jun;18(5):479-84
references.pmid: 17440825
references.citation: Nat Genet. 2006 Nov;38(11):1239-41
references.pmid: 17033622
references.citation: BMC Cancer. 2009 Mar 19;9:86
references.pmid: 19298662
references.citation: Prostate. 2009 Oct 1;69(14):1565-72
references.pmid: 19562736
references.citation: Cancer Res. 1990 Sep 15;50(18):5851-7
references.pmid: 2393854
references.citation: J Natl Cancer Inst Monogr. 2008;(38):1-93
references.pmid: 18559331
references.citation: Nat Rev Genet. 2010 Jan;11(1):31-46
references.pmid: 19997069
references.citation: Cancer Res. 1989 Apr 15;49(8):2175-83
references.pmid: 2702659
references.citation: Evid Rep Technol Assess (Full Rep). 2007 Oct;(159):1-84
references.pmid: 18457477
references.citation: Am J Hum Genet. 2004 Jun;74(6):1175-82
references.pmid: 15122511
references.citation: N Engl J Med. 2008 Jun 19;358(25):2661-3
references.pmid: 18565857
references.citation: J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88
references.pmid: 9747868
references.citation: J Clin Oncol. 2008 Feb 1;26(4):542-8
references.pmid: 18172190
references.citation: N Engl J Med. 2008 Feb 28;358(9):910-9
references.pmid: 18199855
references.citation: Nature. 2009 Oct 8;461(7265):724-6
references.pmid: 19812653
references.citation: Cancer. 2009 Mar 1;115(5):952-61
references.pmid: 19156902
references.citation: Technol Cancer Res Treat. 2010 Apr;9(2):107-21
references.pmid: 20218734
references.citation: Br J Cancer. 2007 Aug 20;97(4):486-93
references.pmid: 17700548
references.citation: Gut. 2003 May;52 Suppl 2:ii10-8
references.pmid: 12651877
references.citation: J Natl Cancer Inst. 2004 Feb 18;96(4):261-8
references.pmid: 14970275
references.citation: Nature. 2005 Oct 27;437(7063):1299-320
references.pmid: 16255080
references.citation: Minerva Endocrinol. 2009 Dec;34(4):295-309
references.pmid: 20046159
references.citation: Cancer Res. 2006 Aug 1;66(15):7810-7
references.pmid: 16885385
references.citation: Genes Dev. 2010 Mar 1;24(5):423-31
references.pmid: 20194435
references.citation: J Natl Cancer Inst. 2005 Jan 5;97(1):30-9
references.pmid: 15632378
references.citation: N Engl J Med. 2005 May 5;352(18):1851-60
references.pmid: 15872200
references.citation: Clin Chem. 1999 May;45(5):739-45
references.pmid: 10222376
references.citation: Pharmacol Ther. 2007 Dec;116(3):496-526
references.pmid: 18001838
references.citation: N Engl J Med. 2008 Jun 26;358(26):2796-803
references.pmid: 18579814
references.citation: Genomics. 2009 Feb;93(2):105-11
references.pmid: 18992322
references.citation: JAMA. 2009 Oct 7;302(13):1429-36
references.pmid: 19809024
references.citation: N Engl J Med. 1997 May 15;336(20):1401-8
references.pmid: 9145676
references.citation: Fam Cancer. 2008;7(4):341-5
references.pmid: 18297415
references.citation: J Natl Cancer Inst. 2008 Jul 16;100(14):1037-41
references.pmid: 18612136
references.citation: Cancer Res. 1991 Sep 15;51(18):4837-44
references.pmid: 1893376
references.citation: Fam Cancer. 2007;6(4):473-82
references.pmid: 17636425
references.citation: J Clin Oncol. 2002 May 1;20(9):2310-8
references.pmid: 11981002
references.citation: J Natl Cancer Inst. 2003 Dec 3;95(23):1758-64
references.pmid: 14652237
references.citation: J Clin Oncol. 2008 Dec 10;26(35):5783-8
references.pmid: 18809606
references.citation: J Clin Oncol. 2010 Feb 10;28(5):893-901
references.pmid: 20065170
references.citation: J Clin Oncol. 2008 Feb 1;26(4):519-20
references.pmid: 18172189
references.citation: Science. 2010 Jan 1;327(5961):78-81
references.pmid: 19892942
references.citation: Lancet. 1998 May 16;351(9114):1451-67
references.pmid: 9605801
references.citation: N Engl J Med. 2003 Feb 6;348(6):538-49
references.pmid: 12571262
references.citation: Nat Rev Genet. 2007 Feb;8(2):151-7
references.pmid: 17230201
references.citation: Breast Cancer Res Treat. 2007 Jan;101(1):113-21
references.pmid: 17115111
references.citation: J Clin Oncol. 2003 Jun 15;21(12):2397-406
references.pmid: 12692171
references.citation: Clin Pharmacol Ther. 2006 Jul;80(1):61-74
references.pmid: 16815318